Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

The new drug circuit

Synthetic biology has historically relied on bacteria as a testing ground for engineering cell behavior through genetic signals. But a small group of researchers have their sights set on redesigning mammalian cells, which have more complex genetic machinery. Daniel Grushkin meets the scientists aiming to reprogram our bodies' cells for a new generation of tailor-made treatments.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout


  1. Chen, Y.Y. et al. Proc. Natl. Acad. Sci. USA 107, 8531–8536 (2010).

    Article  CAS  Google Scholar 

  2. Danino, T. et al. Nature 463, 326–330 (2010).

    Article  CAS  Google Scholar 

  3. Warren, L. et al. Cell Stem Cell 7, 618–630 (2010).

    Article  CAS  Google Scholar 

  4. Gardner, T.S. et al. Nature 403, 339–342 (2000).

    Article  CAS  Google Scholar 

  5. Kramer, B.P. et al. Nat. Biotechnol. 22, 867–870 (2004).

    Article  CAS  Google Scholar 

  6. Ausländer S. et al. Nature 487, 123–127 (2012).

    Article  Google Scholar 

  7. Xie, Z. et al. Science 333, 1307–1311 (2011).

    Article  CAS  Google Scholar 

  8. Kemmer, C. et al. Nat. Biotechnol. 28, 355–360 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Grushkin, D. The new drug circuit. Nat Med 18, 1452–1454 (2012).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research